OMEGA HEALTHCARE INVESTORS INC (OHI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 150M 300M 450M Q3 '21: 281.7M Q4 '21: 249.9M Q1 '22: 249.3M Q2 '22: 244.6M Q3 '22: 239.4M Q4 '22: 144.8M Q1 '23: 218.2M Q2 '23: 250.2M Q3 '23: 242M Q4 '23: 239.3M Q1 '24: 243.3M Q2 '24: 252.7M Q3 '24: 276M Q4 '24: 279.3M Q1 '25: 276.8M Q2 '25: 282.5M Q3 '25: 311.6M Q4 '25: 319.2M Q1 '26: 323M Q2 '26: 328.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-150M 0 150M 300M 450M Q2 '16: 142.2M Q3 '16: 124.3M Q4 '16: 196.9M Q1 '17: 139.2M Q2 '17: 141.1M Q3 '17: -88.2M Q4 '17: 123.1M Q1 '18: 138.1M Q2 '18: 132.7M Q3 '18: 110.7M Q4 '18: 116.1M Q1 '19: 122.2M Q2 '19: 126.5M Q3 '19: 187.2M Q4 '19: 115.9M Q1 '20: 147.7M Q2 '20: 156.5M Q3 '20: -39.5M Q2 '25: 281.2M Q2 '26: 330.9M Q3 '16 Q2 '17 Q1 '18 Q4 '18 Q3 '19 Q2 '20 Q2 '26

Net Income Quarterly

0 150M 300M 450M Q3 '21: 142.8M Q4 '21: 34.2M Q1 '22: 195.2M Q2 '22: 91.9M Q3 '22: 105.1M Q4 '22: 46.7M Q1 '23: 36.8M Q2 '23: 61.5M Q3 '23: 93.9M Q4 '23: 56.5M Q1 '24: 67.4M Q2 '24: 113.9M Q3 '24: 111.8M Q4 '24: 113.3M Q1 '25: 109M Q2 '25: 136.6M Q3 '25: 179.7M Q4 '25: 164.8M Q1 '26: 151M Q2 '26: 362.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

0 90M 180M 270M Q3 '21: 187.3M Q4 '21: 156.5M Q1 '22: 132.2M Q2 '22: 173M Q3 '22: 166.8M Q4 '22: 153.7M Q1 '23: 111.4M Q2 '23: 170.4M Q3 '23: 171M Q4 '23: 165M Q1 '24: 151.5M Q2 '24: 184.1M Q3 '24: 184.9M Q4 '24: 229M Q1 '25: 182M Q2 '25: 239.3M Q3 '25: 226.7M Q4 '25: 230.6M Q1 '26: 215.5M Q2 '26: 217.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '20: 234.5M Q2 '20: 234.5M Q3 '20: 233.7M Q1 '21: 239.9M Q2 '21: 243.9M Q3 '21: 246.6M Q1 '22: 247.6M Q2 '22: 243.3M Q3 '22: 243.3M Q1 '23: 243.2M Q2 '23: 246.1M Q3 '23: 256M Q1 '24: 257.3M Q2 '24: 261.5M Q3 '24: 275.6M Q1 '25: 294.9M Q2 '25: 303.2M Q3 '25: 308.2M Q1 '26: 315.1M Q2 '26: 316.2M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.00 2.00 3.00 Q3 '21: 1.91 Q4 '21: 1.76 Q1 '22: 1.86 Q2 '22: 1.88 Q3 '22: 1.73 Q4 '22: 1.80 Q1 '23: 1.16 Q2 '23: 1.03 Q3 '23: 0.97 Q4 '23: 0.99 Q1 '24: 1.11 Q2 '24: 1.31 Q3 '24: 1.36 Q4 '24: 1.55 Q1 '25: 1.61 Q2 '25: 1.62 Q3 '25: 1.79 Q4 '25: 1.93 Q1 '26: 2.07 Q2 '26: 2.80 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.